Corneal Cross-Linking and Safety Issues

PURPOSE: To compile the safety aspects of the corneal collagen cross-linking (CXL) by means of the riboflavin/UVA (370 nm) approach. MATERIALS AND METHODOLOGY: Analysis of the current treatment protocol with respect to safety during CXL. RESULTS: The currently used UVA dose density of 5.4 J/cm(2) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Spoerl, Eberhard, Hoyer, Anne, Pillunat, Lutz E, Raiskup, Frederik
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052642/
https://www.ncbi.nlm.nih.gov/pubmed/21399770
http://dx.doi.org/10.2174/1874364101105010014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052642/
https://www.ncbi.nlm.nih.gov/pubmed/21399770
http://dx.doi.org/10.2174/1874364101105010014

Ejemplares similares